BALYASNY ASSET MANAGEMENT L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
LXEO
Shares outstanding
54,001,211 shares
Disclosed Ownership
5,394,721 shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 06:04:07 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 9.99% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 9.99% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 9.99% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 9.99% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 9.99% 5,394,721 5,394,721 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self